The Trump administration has cut Medicaid coverage for gender-affirming care, subpoenaed over twenty hospitals and clinics, and asked the DOJ to investigate hospitals for billing fraud. These are not separate decisions. They are a coordinated strategy of attrition designed to make providers too frightened to offer trans healthcare at all.

The individual pieces matter before we look at the shape of them together.

On Tuesday, the administration finalised a rule cutting Medicaid and CHIP funding for hormone therapy, puberty blockers, and surgeries for transgender young people. Seventeen states currently cover some degree of gender-affirming care through these programmes. The administration says this is to "help protect these children." Every major medical organisation that works with trans young people says it is doing the opposite.

On Thursday, Vice President Vance wrote to Attorney General Todd Blanche asking the DOJ to investigate hospitals and paediatric gender clinics for allegedly using misleading billing codes to make insurance companies cover procedures they otherwise would not. The claim is that providers have been deceptive, motivated not by ideology but by profit. The report Vance cited to support this was authored, the reporting makes clear, almost entirely by contributors from conservative and religious organisations that already oppose gender-affirming care, or by individuals who have personally campaigned against it. It is not an independent assessment. It is a document designed to produce the conclusion it reached.

And then there are the subpoenas: more than twenty hospitals, clinics, and individual doctors, served with demands for personnel files, patient records, and communications with pharmaceutical companies. A federal appeals court upheld one such subpoena against telemedicine provider QueerDoc.

Three things in one week, none of them isolated, all of them pointing in the same direction.

What this actually is

This is not enforcement. Enforcement implies a clear legal violation that needs to be pursued. What I am watching here is something different: a deliberate campaign to make the legal, financial, and reputational cost of providing trans healthcare so high that providers decide it is not worth it. You do not need to win a court case to achieve that. You just need to generate enough fear.

Think about what it looks like from inside a hospital right now. Your institution has received a federal subpoena. Your billing practices are being characterised publicly as fraudulent, in a letter from the Vice President of the United States. A report exists, however flimsy its authorship, that a future lawsuit or congressional hearing could wave around. Your lawyers are advising caution. Your board is asking questions. Your communications team is worried about the headlines.

You have not been found guilty of anything. You have not lost a legal challenge. No court has ruled that the care you provide is unlawful. But the calculus of risk has shifted, and some institutions will decide to stop. Quietly, gradually, with regret perhaps, but they will stop. And the young people in their care will have nowhere to go.

That is the strategy. It does not require a Supreme Court ruling. It does not require Congress to pass a law. It just requires enough legal noise that hospitals run out of courage.

Who actually pays for this

The administration's framing inverts the cost entirely. They claim to be protecting children. What they are doing is removing the medical care that the international clinical consensus says those children need, while simultaneously making it harder for the providers who offer that care to continue doing so.

A young person who was relying on Medicaid to cover their hormone prescription does not have an alternative pathway waiting. Families who qualified for Medicaid are, by definition, families for whom private care is not simply a matter of choosing a different provider. The Medicaid cut is not a redirection of care. It is, for many families, the end of it.

And for the young people whose hospital quietly stops its gender clinic, the effect is identical: care gone, not because a judge said so, but because the institution decided the fight was not worth having. That young person did not lose a legal battle; their hospital lost its nerve.

Puberty does not pause while any of this plays out. Every month of an unwanted puberty is a permanent physical change. The administration frames delay as caution, but it is harm, delivered slowly and with paperwork.

On the fraud claims

The billing fraud allegation deserves a direct response, because it will be repeated and it is worth understanding what it actually says.

The claim is that some providers used diagnostic codes that allowed insurance coverage of procedures those insurers would otherwise have declined. If that is true in specific cases, it should be investigated through normal channels. But the framing in Vance's letter goes much further: it asserts a systemic, profit-motivated conspiracy across paediatric medicine, bolstered by a report whose authors were selected for their pre-existing opposition to the care they were asked to assess.

Major medical groups have said clearly that the administration's moves misrepresent the current medical consensus. The Endocrine Society, WPATH, the American Academy of Pediatrics, and others have all endorsed gender-affirming care as evidence-based and necessary. The administration is not engaging with that evidence. It is constructing an alternative account, authored by its own allies, to justify legal action it had already decided to take.

That is not how medicine is supposed to work. And it is not how law is supposed to work either.

What trans young people and their families need to know

If you or your child is currently receiving gender-affirming care through Medicaid or through a hospital that has received a subpoena, the most important thing I can tell you is this: get advice specific to your situation, and do it now rather than waiting to see what happens. Care does not always disappear overnight, but providers under legal pressure sometimes make changes quickly and without much notice.

For anyone trying to access care or maintain it, GenderGP continues to offer gender-affirming medical care, including hormones and ongoing prescribing and monitoring, working to international clinical standards. It exists precisely because public and institutional pathways can and do close without warning.

What is happening in the United States right now is not the end of trans healthcare. It is a sustained attempt to make it inaccessible by making it dangerous to provide. The care itself remains what it always was: evidence-based, life-changing, and necessary. The people who need it remain who they always were. The task is to stay connected to what is still possible, even when the noise is designed to make that feel impossible.

If there is a news story you would like me to cover then just let Sammy know.

Dr Helen Webberley is a gender specialist, medical educator, and advocate, and the founder of GenderGP. She writes about gender diversity, trans healthcare, and the lives at the centre of both.